Gibralt Capital Corpoation is a Vancouver, Canada based alternative asset manager.
Gibralt Capital Corporation is a Vancouver, Canada based alternative asset manager. Gibralt focuses on investments that span the globe, but with a specific presence in North America.Gibralt’s investments include private equity, real estate, public market securities, and credit-oriented funds. Gibralt’s opportunistic strategy targets attractive absolute returns. These strategies may exhibit short term volatility, exposure to a less liquid set of investments and varying correlation to equity, credit and interest rate markets. They also may exhibit a higher degree of manager concentration relative to broadly diversified strategies in order to emphasize particularly attractive current market opportunities.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Apr 16, 2014
Epirus Biopharmaceuticals
|
Series B | $36M | Biotechnology | — |